Inventor · disambiguated record
William Louis Macias
Also filed as: MACIAS WILLIAM L · MACIAS WILLIAM LOUIS
5 granted patents·7 pending applications·33 citations·filing 1998–2023
77Inventor score
Top patents by PatentIndex Score
12 records- 0168US11926669B2Anti-FcRn antibody or antigen binding fragment thereof with improved stabilityHANALL BIOPHARMA CO LTD·Filed 2023·Granted Mar 12, 2024·0 cites·20 claims
- 0262US2025223362A1Anti-fcrn antibody or antigen binding fragment thereof with improved stabilityHANALL BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0351US6610728B2Method for treatment of non-rheumatoid arthritisLILLY CO ELI·Filed 1998·Granted Aug 26, 2003·12 cites·12 claims
- 0443US5972988AMethod for treatment of chronic bronchitis using indole compoundsLILLY CO ELI·Filed 1998·Granted Oct 26, 1999·10 cites·8 claims
- 0541US2011171200A1Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compoundWALLEY KEITH R·Filed 2009·Application pending·0 cites
- 0641US2003087944A1Method for the treatment of renal dysfunction with spla2 inhibitorsFiled 2001·Application pending·0 cites
- 0740US2002198138A1Combination therapy for the treatment of inflammatory and respiratory diseasesFiled 2000·Application pending·0 cites
- 0840US2003092767A1Combination therapy for the treatment of inflammatory and respiratory diseasesFiled 2000·Application pending·0 cites
- 0939US6340699B1SPLA2 inhibitor compounds for treatment of diseaseLILLY CO ELI·Filed 1999·Granted Jan 22, 2002·5 cites·12 claims
- 1039US2004110825A1Method for treating sepsisFiled 2001·Application pending·0 cites
- 1139US2010209413A1Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of deathWALLEY KEITH R·Filed 2008·Application pending·0 cites
- 1238US6576654B1Method for the treatment of cystic fibrosisLILLY CO ELI·Filed 1998·Granted Jun 10, 2003·6 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when William Louis Macias files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →